C atheter-associated urinary tract infection (CAUTI) remains a challenging health care-associated infection (HAI) to reduce in many hospitals, despite the development of multicomponent "bladder bundle" interventions, checklists for aseptic urinary catheter insertion and maintenance care steps, more recently refined catheter use criteria to reduce inappropriate use in medical and surgical patients, mandatory surveillance, and hospital complication penalties (1) (2) (3) (4) (5) (6) (7) (8) (9) . Fortunately, the evidence base for interventions to prevent CAUTI across clinical settings has been rapidly growing, as re-ported in multiple systematic reviews (3, 10 -12) . Compared with standard care, the pooled CAUTI incidence rate ratio from a recent meta-analysis of multifaceted interventions was 0.54 (95% CI, 0.45 to 0.66); however, funnel plots indicate potential concern about publication bias, which highlights the importance of publishing interventions that are not successful (12) .
Catheter-associated urinary tract infection (CAUTI) remains an expensive complication, though the additional cost to a hospitalization varies by assessment method from a few hundred dollars to thousands of dollars (13, 14) . In addition, U.S. hospitals no longer receive additional payment for treatment of a hospitalacquired CAUTI as a comorbid diagnosis (6) . Hospitals also are subject to expensive reductions in the Medicare payment rate to the hospital by multiple valuebased purchasing policies that compare and penalize hospital performance by using a composite rate of
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Web-Only CME/MOC activity hospital-acquired complications that includes CAUTI (6, 15) .
Success in prevention of CAUTI remains variable (3, 10, 12, 16, 17) . The most recent CAUTI surveillance data from the National Healthcare Safety Network (NHSN) did not demonstrate improvement overall from 2009 to 2014, though there was progress in the nonintensive care unit (ICU) setting during this period (similarly demonstrated in a large national collaborative), and progress in both ICU and non-ICU settings between 2013 and 2014 (16, 18) . A recent large study of HAI point prevalence in acute care hospitals did demonstrate statistically significant reductions in both the percentage of patients with CAUTI and patients with urinary catheters between 2011 and 2015, in a patient population that was primarily (85%) in the non-ICU setting (19) . To support hospitals that are still struggling with CAUTI and other HAIs, the Centers for Disease Control and Prevention (CDC) funded a national project called STRIVE (States Targeting Reduction in Infections via Engagement). This was a multimodal hospitallevel intervention, externally facilitated by state-level partners, that targeted acute care, long-term acute care, and critical access hospitals, including both ICUs and non-ICUs, with elevated HAI rates as defined by the CDC's Targeted Assessment for Prevention (TAP) strategy (20, 21). In this article, we summarize the quantitative analyses and results describing the effect of this initiative on CAUTI outcomes and urinary catheter utilization.
METHODS
In brief, the CDC STRIVE initiative aimed to accomplish several goals (20). Improving implementation of infection prevention and control (IPC) efforts was prioritized by providing and coaching on use of IPC assessment tools, providing the CDC's TAP strategy resources, and offering technical and implementation assistance to improve IPC practices. The STRIVE initiative also aimed to strengthen relationships between state-level partners, such as state hospital associations and state health departments, to both help sustain improvements made in this project and bolster the foundation for rapid, efficient response and cooperation between state-level partners and hospitals when challenged with new infectious hazards.
Because improving implementation of IPC practices was a priority in hospitals with a disproportionately high burden of HAIs, rates of Clostridioides difficile infection, central line-associated bloodstream infection, CAUTI, and hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infection were chosen as measures to evaluate the success of STRIVE. In this article, we describe the quantitative results of cohorts 2 through 4 of this collaborative (cohort 1 was a pilot), which were active between November 2016 and May 2018, by using CAUTI and urinary catheter utilization outcome data. The qualitative assessment results for this collaborative are detailed elsewhere (22) .
Data Sources
Data for this analysis came from 3 data sources. First, the quantitative outcomes regarding CAUTI and urinary catheter utilization were obtained as reported by participating STRIVE hospital units (including ICUs and non-ICUs) to the NHSN surveillance program (8) . Second, hospital characteristics, such as bed size, teaching status, urban or rural location, ownership, and hospital type (that is, acute care, long-term care, critical access), were obtained from the 2015 American Hospital Association Annual Survey of Hospitals (23) . On the basis of the Centers for Medicare & Medicaid Services designations, hospitals were considered "critical access" if they had no more than 25 inpatient beds, had short lengths of stay (average ≤4 days), and were located more than 35 miles from the nearest hospital or served a physically remote community.
The STRIVE hospitals were also asked to complete either the CDC Infection Control Assessment and Response (ICAR) assessment tool (24) or the related Practice Change Assessment (PCA) tool at baseline and at the end of the intervention period to assess HAI prevention practices, policies, and procedures. The PCA included questions from the more comprehensive ICAR tool and included 29 questions focused on CAUTI prevention. The goal of these tools was to allow the hospitals to perform a self-assessment to identify their gaps in IPC practices. Ideally, use of these tools could help hospitals prioritize needs and motivate use of the interventions provided by this project to address their specific gaps. We are unaware of these specific tools being used previously as part of a large-scale intervention like this collaborative.
Study Design and Cohort Recruitment
This was a prospective, nonrandomized, externally facilitated quality improvement initiative targeting acute care, long-term acute care, and critical access hospitals that were clustered within states, including ICUs and non-ICUs clustered within hospitals.
This project's primary recruitment target was hospitals that had a high burden of C difficile infection, as well as a high burden of at least 1 of the following HAIs: central line-associated bloodstream infection, CAUTI, or methicillin-resistant S aureus bloodstream infection. "High burden" of HAI was defined as having a cumulative attributable difference above the first tertile (the worst one third) (25). The cumulative attributable difference is obtained by subtracting a numerical prevention target (the product of a predicted number of HAIs and a standardized infection ratio goal based on NHSN targets from the Department of Health and Human Services) from an observed number of HAIs. Additional details of the recruitment strategy are published elsewhere (20). Cohorts differed by the state targeted for recruitment, on the basis of the list of states for highest priority for targeting by the CDC in communication with Health Research & Educational Trust (HRET).
A pilot cohort was recruited in June 2016, was active over 10 months, and informed the refinement of the recruitment strategy, intervention development, and implementation. Here we provide the results from the 3 later cohorts with a 12-month pre-and postintervention period, active between November 2016 and May 2018. Each cohort contained a balanced mix of acute care, long-term acute care, and critical access hospitals.
The University of Michigan Medical School Institutional Review Board reviewed the study and determined that it did not meet the regulatory definition of research involving human subjects.
Intervention
The intervention was available to all participating hospitals and included several components (Appendix Figure 1 , available at Annals.org), summarized here briefly. Intervention development is described in more detail elsewhere (20, 26 -28). The ICAR/PCA was provided to help hospitals and units self-identify gaps in general infection control and HAI-specific prevention, so that they could then identify their HAI focus and prioritize interventions for implementation. Brief, Webbased, on-demand modules were developed, including modules for onboarding participating hospitals; providing education on "foundational" or horizontal infection control practices (such as hand hygiene, use of personal protective equipment, and antimicrobial stewardship) and HAI-specific prevention strategies; and TAP resources.
The STRIVE project focused on strengthening foundational aspects of infection prevention (such as hand hygiene and use of personal protective equipment) within the hospital, and utilized cross-cutting strategies to address change needed within the hospital culture. Culture change was addressed in specific on-demand modules, such as the modules on uber-adaptive strategies for infection prevention and patient and family engagement. The socioadaptive aspects of culture change were also addressed through messaging within the modules and Learning Action Forums that gave strategies to deal with staff engagement, staff turnover, competency-based training, audits, and feedback.
Another focus of the STRIVE project was to specifically expand knowledge and application of the CDC's TAP strategy (25). Throughout the modules, the TAP strategy was referenced. To drive uptake of the TAP strategy within STRIVE, hospitals and state partners were invited to participate in a series of 4 webinars sponsored by HRET. Multiple states conducted presentations on the TAP strategy where hospital-specific TAP reports were shared for group learning. Additional education on how to use the TAP strategy was provided during one-on-one coaching and on-site visits. The TAP strategy was also discussed and referenced throughout the 3-year program on monthly national Learning Action Forums.
The HAI-specific prevention strategies were organized and prioritized by using a 2-tiered approach. Tier 1 focused on 5 basic prevention strategies to implement first. The first step of tier 2 was completion of an HAI-specific guide to patient safety self-assessment tool to help hospitals prioritize remaining key HAI strategies to implement, which could include tier 1 interventions needing better implementation or other interventions within tier 2, which tend to be more costly and resource-intensive than those in tier 1 (28). There were 7 Web-based, on-demand CAUTI modules. The CAUTI-specific modules included tier 1 interventions focused on placing urinary catheters only for appropriate indications, encouraging use of alternatives to indwelling catheters, ensuring proper aseptic catheter insertion and maintenance, prompting removal of unnecessary catheters, and implementing urine culture stewardship. The CAUTI-specific prevention strategies in tier 2 included completing the CAUTI guide to patient safety (29) , conducting catheter rounds to target education and appropriate use, feeding back of infection and catheter use data to clinical staff in real time, observing and documenting competency of catheter insertion, and performing full root-cause analyses of all CAUTIs. Monthly webinars reinforced educational content and implementation strategies and provided coaching by subject-matter experts. State partners were also required to lead at least 1 inperson meeting for hospitals in their state, as an opportunity to bring hospitals and state partners together to support building relationships in a protected time and space.
Although not an intervention component or evaluation tool available to all participating hospitals, state hospital associations-with the assistance of other state partners-were expected to conduct in-person site visits with at least 50% of their participating STRIVE hospitals during the 12-month intervention period for each cohort. The purpose of this visit was to provide in-person technical assistance with such tasks as data collection, submission, and use of self-assessment, and additional coaching to hospitals and units regarding general IPC 
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practices and HAI-specific prevention. There was no standardized process for how state hospital associations selected hospitals for a site visit, nor the data collection or agenda during the visit. Thus, the site visits could function as a type of additional intervention or implementation facilitator for hospitals that received them, beyond the routine intervention components received by all STRIVE hospitals.
Participating hospitals in cohorts 2 through 4 were encouraged to complete the ICAR/PCA questionnaires at baseline and in follow-up, all modules involving onboarding, foundational infection control practices, TAP resources, and the HAI-specific prevention strategies for each of the HAIs they chose to focus on in this program (CAUTI, central line-associated bloodstream infection, C difficile infection, or methicillin-resistant S aureus bloodstream infection). The program was designed to be flexible for the participating hospitals to be able to prioritize and focus on the interventions they felt would be most important to address their gaps in infection prevention. Module participation was initially tracked by requiring participants to log in with a username and password; however, early in the project, we learned that the password requirement was an important barrier to participation, so the modules were converted to open access. Hospitals were encouraged to track their own staff's participation in the intervention activities, but were not required to report participation to the national program. Hospitals could remain with the program and make use of the intervention resources regardless of participation level.
Outcomes
The primary outcome was the overall CAUTI rate, calculated as the number of CAUTIs per 1000 urinary catheter-days, from all hospital types studied (acute care, long-term acute care, and critical access) and all ward types (ICU and non-ICU). The overall urinary catheter device utilization ratio was the secondary outcome, calculated as urinary catheter-days per 100 patientdays. Cases of CAUTI and urinary catheter use were recorded through monthly data submission to the NHSN, which was provided for participating hospitals to the STRIVE team.
Statistical Analysis
Descriptive statistics with measures of variation (when feasible) were used to summarize participating hospital characteristics as mean (SD), median (interquartile range), and number (percentage). Unadjusted CAUTI rates were calculated as the ratio of total number of CAUTIs (as numerator) reported per month by participating hospitals over the total number of urinary catheter-days that same month (as the denominator); this measure of CAUTIs per urinary catheter-days was then multiplied by 1000 to yield CAUTIs per 1000 catheter-days. Urinary catheter device utilization was calculated by the ratio of total catheter-days per month over total patient-days per month; this measure of urinary catheter use per patient-day was then multiplied by 100 to yield urinary catheter utilization rate per 100 patient-days.
Raw aggregate CAUTI and urinary catheter utilization rates were tabulated on a monthly basis for the pre-and postintervention periods. Ninety-five percent CIs were calculated by using a bootstrap approach in which we resampled the data at each time point 10 000 times, recalculating the CAUTI incidence rate in each sample. A 95% normal-based CI was then calculated on the basis of the bootstrap estimates. To display the aggregated pre-and postintervention results by hospital, a Sankey bar graph was generated in SAS software (SAS Institute) by using the macro %sankeybarchart (30) . All analyses were conducted in Stata, version 13 (StataCorp); SAS, version 9.4; and R Project (R Foundation for Statistical Computing).
Role of the Funding Source
This study was funded by the CDC via a contract that specified program objectives and deliverables and general project oversight, and also enabled provision of NHSN data for outcome analysis. The CDC funded the national STRIVE project team but had no role in the design of the study, writing of the article, or analysis of the data.
RESULTS

Hospital Characteristics
A total of 404 hospitals were enrolled for cohorts 2 through 4. Cohort 2 was active between November 2016 and October 2017, cohort 3 was active between April 2017 and March 2018, and cohort 4 was active between June 2017 and May 2018. The flow diagram in Appendix Figure 2 (available at Annals.org) shows the quiring demonstrated competency). More than two thirds (70.9%) of hospitals had a physician or nurse champion for CAUTI, 85.2% had a process or method to trigger daily assessments of catheterized patients, and 70.9% routinely audited adherence to daily assessment of the need for a urinary catheter.
Outcomes
Monthly rates and 95% CIs for CAUTI and catheter utilization over the course of the project are shown in Appendix Figure 3 and Appendix Table 1 (available at Annals.org). In the preintervention period, there were 3279 cases of CAUTI, 2 930 416 catheter-days, and 13 654 721 patient-days of observation ( Table 2 ). The aggregate CAUTI rate was 1.12 per 1000 catheter-days, and the urinary catheter utilization was 21.46 per 100 patientdays. In the postintervention period, there were 2906 cases of CAUTI, 2 800 122 catheter-days, and 14 118 624 patient-days of observation. The aggregate CAUTI rate 
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In this Sankey bar chart, the connecting segments show how hospitals changed from the pre-to the postintervention periods. The slopes of the connecting segments should be interpreted cautiously because some segments connecting to the same rate category are increasing or decreasing visually but indicate no change in rates in these hospitals. Only segments that connect to a different category indicate changes in rates from the preto the postintervention period. CAUTI = catheter-associated urinary tract infection.
Results of a CAUTI Prevention Intervention was 1.04 per 1000 catheter-days, and the urinary catheter utilization was 19.83 per 100 patient-days. Rates during the pre-and postintervention periods and the change between the 2 periods at the hospital level are shown in the Figure and Appendix Table 2 . Six hospitals reporting any outcome data only did so for either the pre-or postintervention period. As such, change evaluations were performed on a total of 355 hospitals. A total of 71 (20.0%) of reporting hospitals had CAUTI rates of zero during both periods, whereas 116 (32.7%) of hospitals achieved the CDC reduction goal of 25% in the postintervention period relative to the preintervention period. Among the hospitals that achieved the reduction goal, 90 (77.6%) were acute care; 68 (61.8%) were nonteaching; 81 (73.6%) were urban; and 73 (66.4%) were nongovernment, nonprofit hospitals.
DISCUSSION
We report quantitative outcomes for CAUTI and urinary catheter utilization as reported to the NHSN for this multimodal intervention targeting hospitals with a high burden of C difficile infection, as well as a high burden of at least 1 of the following HAIs: central lineassociated bloodstream infection, CAUTI, or methicillinresistant S aureus bloodstream infection. No substantial reductions occurred in the incidence of CAUTI or urinary catheter utilization. No data are available at this time to compare these results with national trends in CAUTI and urinary catheter utilization in the 2016 -2018 period of this study.
Despite multicomponent interventions delivered by on-demand modules, live webinars, coaching calls, in-person meetings, and a 2-tiered approach to help hospitals prioritize interventions to reduce CAUTI and urinary catheter use, no substantial quantitative improvements occurred. Several reasons could explain this finding. With targeted hospitals having a high burden of 2 HAIs, an externally facilitated intervention such as this may not have adequately provided the support these hospitals needed to tackle such difficult HAIs at the bedside. Our project provided extensive educational resources-which served primarily to address knowledge deficits-but in the end probably did not address several barriers that can affect the success of interventions aiming to change clinician behavior that are often experienced by hospitals that are not performing well. These include rapid staff turnover, unstable leadership, variation in support of IPC programs, or less effective laboratory diagnostic stewardship (especially for urine culture orders) (31-33). These challenges, along with other "system shocks," make it difficult for even a very dedicated and experienced team focusing on one challenging problem, such as CAUTI, given anticipated recurrent distraction to address other pressing issues (32) . This project also ambitiously targeted multiple types of acute care hospitals (acute care, long-term acute care, and critical access), which care for different types of patients and have different clinical staffing models. Interventions may need to be tailored to setting, although these same methods of education and facilitation have been previously successful in non-ICU acute care settings and nursing home units (18, 34) .
Our analyses and intervention had limitations. First, over time, with changing definitions of NHSN CAUTI, this surveillance event has become rarer, which could affect the power to detect substantial changes. As illustrated in the Figure, the majority of hospitals (61%) already had CAUTI rates of 1.0 or less before the intervention. Second, owing to the before-and-after quasiexperimental design, confounding variables could have affected the results. Third, we were unable to assess the impact of individual components of this multicomponent intervention. Fourth, no intervention fidelity measures were collected. Therefore, we were unable to assess how well the project resources were utilized, or whether hospitals that utilized specific resources were more successful in reducing CAUTI or urinary catheter use. Fifth, we initially required a password to access educational modules to track utilization; however, this proved to be a barrier for participating hospitals, and we therefore changed all materials to be open access to encourage use. Sixth, we were unable to account for patient characteristics in our analysis. Finally, our intervention was brief, with a relatively short assessment period. It may take longer for STRIVE interventions to affect infection rates.
Some lessons learned for consideration by future collaboratives include: 1) conducting a readiness assessment during recruitment to ensure that sites have the necessary software and can resolve firewall issues that can be barriers to accessing Web-based education; 2) enhancing the module and webinar access strategies so that they remain simple to find and access online, but also track participation; and 3) investing additional resources to provide in-person site visits to monitor and encourage intervention fidelity early in the program.
In conclusion, our multimodal intervention aimed at reducing CAUTI and reducing urinary catheter use in hospitals with a high burden of hospital infections achieved neither result. The reasons are unclear. Despite overall progress in preventing HAI (19) , enhanced attention on hospitals struggling to improve appears warranted. Finally, an updated meta-analysis finds that over 50% of CAUTIs are preventable (12), so we encourage others not to be discouraged by our results, but to continue to work to find ways to reduce CAUTI. We can and should do more to prevent this harm.
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